WOSCOPS Trial Summary WOSCOPS trial was a double-blind, parallel-group, randomized, placebo-controlled trial that was designed to assess the benefit of pravastatin in reducing CV events…
WOEST Trial Summary: The WOEST trial was a multicenter, open-label, randomized, controlled clinical trial to assess if clopidogrel alone could reduce bleeding risk compared to…
WARFASA Trial Summary The WARFASA trial was a multicenter, double-blinded, randomized, placebo-controlled trial to assess whether aspirin could reduce the recurrence of venous thromboembolism (VTE)…
VOYAGER PAD trial aimed to determine if adding rivaroxaban to aspirin would affect outcomes in patients with peripheral arterial disease undergoing stenting. The trial seems…
VITAL Trial (Vit D3) Summary The VITAL trial (Vit D3) was a randomized, two-by-two factorial design, placebo-controlled trial to assess whether supplementation with Vitamin D3…
VITAL N-3 Trial This VITAL trial was a randomized, two-by-two factorial design, placebo-controlled trial to assess whether supplementation with n-3 fatty acids reduces risks of…
The VICTORIA trial was a randomized controlled trial that tested the use of vericiguat in patients with heart failure with reduced ejection fraction. Vericiguat is…
Why did researchers conduct the VEST trial? The researchers carried out the VEST trial (Wearable cardioverter-defibrillator after myocardial infarction) to find out if wearable cardioverter-defibrillators…